Company / Operating Cash Flow
PURE BIOSCIENCE, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$2.0M
FY2025
5-year range
-$3.3M / -$1.2M
FY2021-FY2025
Trend
+20.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$3M to -$2M over the past 2 years.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from -$3M to -$2M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 20.4% year-over-year.
- Peak operating cash flow was recorded in FY2020.
- Lowest operating cash flow in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.0M | +20.4% |
| FY2024 | -$2.5M | +22.8% |
| FY2023 | -$3.3M | -35.6% |
| FY2022 | -$2.4M | -107.2% |
| FY2021 | -$1.2M | -274.4% |
| FY2020 | $669.0K | +122.4% |
| FY2019 | -$3.0M | +23.1% |
| FY2018 | -$3.9M | +14.8% |
| FY2017 | -$4.6M | +8.6% |
| FY2016 | -$5.0M | +17.7% |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026